Plasma Protein and Related Products Recommendations

Shih A, Morrison D, Rosinski K, Cameron T, LeFrense J, Covello T, Blain H, Gettle N, Holmes M, Aseltine L, Pour P, Sewell H. Position Statement on Patient Support Program Best Practices Pertaining to Out of Hospital Transfusions [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; 2026 Oct 13 [cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/position-statement-patient-support-program-best-practices-pertaining-out-hospital

Lett R. NAC Statement on Factor XIII Concentrate Use [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; April 12, 2018 [updated 2024 07 17; cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/nac-statement-factor-xiii-concentrate-use-0

Lett R. NAC Statement on Recombinant Factor VIIa [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; April 12, 2018 [updated 2024 07 18; cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/nac-statement-recombinant-factor-viia

Sidhu D, Tinmouth A, Shih A, Morrison D, Prokopchuk-Gauk O, Musuka C, Conrad D, Rajappannair L, Webert K, Leclerc P, McIntyre L, Teklehaimanot S. Statement on Immunoglobulin Utilization and Intravenous Immunoglobulin Brand Switching [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; 2021 Mar 10 [updated 2026 10 13; cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/statement-immunoglobulin-utilization-and-intravenous-immunoglobulin-brand-switching

Prokopchuk-Gauk O, Shih A, Nahirniak S, et al. NAC Statement on Fibrinogen Concentrate Use in Acquired Hypofibrinogenemia [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; December 15, 2014 [updated 2025 02 26; cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/nac-statement-fibrinogen-concentrate-use-acquired-hypofibrinogenemia

Sidhu D, Shih A. Statement on Clinical Equivalency of Select Fractionated Plasma Protein Products [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; 2022 Jan 17 [updated 2026 09 17; cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/statement-clinical-equivalency-select-fractionated-plasma-protein-products